SOPHiA GENETICS Unveils Upgraded DDM Platform for Healthcare
The new generation of the SOPHiA DDM integrates the latest advancements in data processing and technology, providing customers with an enhanced experience and improved capabilities.
SOPHiA GENETICS (Nasdaq: SOPH), a leader in cloud-native healthcare technology, has launched the next version of its SOPHiA DDM™ Platform. This platform is designed to revolutionize the way healthcare professionals utilize data. With its state-of-the-art architecture, it efficiently manages large volumes of data, ensuring users gain enhanced capabilities and quicker access to insights.
As cancer rates continue to rise globally, the understanding of these diseases has become increasingly complex. Every day, new therapeutic solutions emerge, highlighting the essential role of data in accurately diagnosing conditions, selecting appropriate treatments, and guiding drug development. Since its launch in 2015, the first generation of SOPHiA DDM™ has been instrumental in advancing data-driven medical practices, achieving over 1.8 million genomic analyses each month, and establishing itself as a leader in the healthcare field.
With the growing reliance on data, SOPHiA GENETICS remains at the forefront of innovation in data-driven medicine. The newly launched SOPHiA DDM™ Platform features a web-based architecture for rapid data processing. By utilizing modern microservices and advanced cloud computing technologies from industry leaders, this platform significantly speeds up data computations. As a result, customers receive insights more quickly, improving their operational workflows.
A standout feature of this new platform is its ability to introduce innovative functionalities, including a whole genome sequencing application that is set to be released. This application, along with multimodal analytics, can effectively handle complex and substantial data sets, offering significant advantages to users who work with diverse data modalities.
Integrated Analytics for Holistic Healthcare Solutions
The latest version of the SOPHiA DDM™ offers integrated genomic, radiomic, and multimodal analytics all within a single, user-friendly workspace. Healthcare professionals can customize their experience by selecting applications that align with their specific analytical needs.
Genomic Analytics
This module efficiently processes genomic data in FASTQ and VCF formats, enabling precise calling, annotation, and preliminary classification of oncogenic and pathogenic variants.
Radiomic Analytics
Utilizing various imaging modalities such as CT scans and MRI, this module segments important anatomical regions and extracts essential radiomic features for further analysis.
Multimodal Analytics
This feature integrates data from both the genomic and radiomic modules, along with clinical, biological, and histological insights, to develop and validate predictive models tailored to individual patients.
Zhenyu Xu, Chief Scientific Officer at SOPHiA GENETICS, stated, "As our understanding of complex diseases progresses, it’s vital to adapt our solutions to manage this complexity with both speed and accuracy. Our clients rely on us for innovative offerings that streamline their processes. The latest version of our platform is transforming the user experience by merging advanced AI technologies with multimodal data to deliver actionable insights that enhance precision medicine."
Abhimanyu Verma, Chief Technology Officer, highlighted the commitment to evolving technology to meet user needs. He remarked, "As healthcare technology infrastructures advance globally, we are eager to continue providing exceptional solutions that empower our clients. The new generation of our platform will allow us to quickly respond to changing client demands and efficiently introduce new functionalities."
About SOPHiA GENETICS
SOPHiA GENETICS, a notable entity in healthcare technology (Nasdaq: SOPH), is dedicated to democratizing access to data-driven medicine. The company’s mission is to leverage artificial intelligence to extract insights that facilitate high-quality patient care worldwide. Their flagship SOPHiA DDM™ platform analyzes intricate genomic and multimodal data to deliver real-time, actionable insights, benefiting a vast network of hospitals and laboratories globally.
SOPHiA GENETICS' solutions are intended for research purposes only and should not be used in diagnostic procedures unless specified otherwise. For relevant product information pertaining to different countries, please reach out to [email protected].
Frequently Asked Questions
What is the SOPHiA DDM™ Platform?
The SOPHiA DDM™ Platform is an advanced cloud-native solution designed to analyze genomic and multimodal data, providing actionable insights for healthcare.
What innovations does the new generation of SOPHiA DDM™ offer?
The updated platform includes improved data processing capabilities, integrated analytics, and the ability to deliver insights rapidly, all aimed at enhancing patient care.
How does SOPHiA GENETICS support healthcare professionals?
SOPHiA GENETICS enhances workflows by offering innovative solutions that integrate AI with various data types, promoting precision in healthcare delivery.
What types of analytics are included in the new platform?
The platform features genomic, radiomic, and multimodal analytics, allowing users to effectively analyze data across different modalities.
Who can benefit from using SOPHiA DDM™?
Hospitals, laboratories, and biopharmaceutical organizations can utilize the SOPHiA DDM™ Platform to enhance their data-driven approaches and improve patient outcomes.
